Related Experiment Videos
[Lipoprotein (alpha) as a risk factor for myocardial infarction]
Zhonghua Nei Ke Za Zhi
|December 1, 1991
Summary
Serum lipoprotein (alpha) levels are significantly elevated in myocardial infarction survivors. This finding suggests lipoprotein (alpha) may be an independent risk factor for coronary heart disease, warranting further investigation in cardiovascular health.
Area of Science:
- Cardiovascular Medicine
- Lipidology
- Biochemistry
Context:
- Investigating biomarkers for coronary heart disease (CHD) risk.
- Understanding the role of lipoprotein (alpha) [Lp(alpha)] in post-myocardial infarction (MI) patients.
Purpose:
- To determine Lp(alpha) levels in myocardial infarction survivors (MIS).
- To compare Lp(alpha) levels in MIS with healthy subjects and a hypertension group.
- To assess the relationship between Lp(alpha) and other lipid parameters.
Summary:
- Lp(alpha) levels were significantly higher in 105 MIS compared to healthy individuals and a hypertension cohort.
- No correlation was found between Lp(alpha) and apolipoprotein B, apolipoprotein AI, cholesterol, triglyceride, or high-density lipoprotein cholesterol.
- Elevated Lp(alpha) in MIS suggests its potential as an independent risk factor for CHD.
Impact:
- Highlights Lp(alpha) as a potential novel biomarker for CHD risk stratification.
- Informs future research on the pathogenic mechanisms of Lp(alpha) in cardiovascular disease.
- May guide the development of targeted therapies for preventing recurrent cardiovascular events.